Accounts Submission

LASCAUX PHARMACEUTICALS LIMITED - Company Information

Company Accounts and Tax Online 03230603 Board of Directors 1.10.20 30.9.21 30.9.21 No description of principal activity false iso4217:GBP xbrli:pure 03230603 2019-10-01 2020-09-30 03230603 2021-09-30 03230603 2020-10-01 2021-09-30 03230603 2020-09-30 03230603 countries:EnglandWales 2020-10-01 2021-09-30 03230603 curr:PoundSterling 2020-10-01 2021-09-30 03230603 uk-bus:PrivateLimitedCompanyLtd 2020-10-01 2021-09-30 03230603 uk-bus:Micro-entities 2020-10-01 2021-09-30 03230603 uk-bus:AuditExempt-NoAccountantsReport 2020-10-01 2021-09-30 03230603 uk-bus:FullAccounts 2020-10-01 2021-09-30 03230603 uk-bus:RegisteredOffice 2020-10-01 2021-09-30 03230603 uk-bus:Director1 2020-10-01 2021-09-30 03230603 uk-bus:Director1 2020-10-01 03230603 uk-bus:Director1 2021-09-30 03230603 core:AfterOneYear 2021-09-30 03230603 core:AfterOneYear 2020-09-30 03230603 core:WithinOneYear 2021-09-30 03230603 core:WithinOneYear 2020-09-30 03230603 core:WithinOneYear 2020-10-01 2021-09-30 03230603 core:AfterOneYear 2021-09-30 03230603 core:AfterOneYear 2020-09-30 03230603 core:AfterOneYear 2020-10-01 2021-09-30 03230603 core:ShareCapital 2021-09-30 03230603 core:ShareCapital 2020-09-30 03230603 core:RevaluationReserve 2021-09-30 03230603 core:RevaluationReserve 2020-09-30 03230603 core:RetainedEarningsAccumulatedLosses 2021-09-30 03230603 core:RetainedEarningsAccumulatedLosses 2020-09-30 03230603 1 2020-10-01 2021-09-30

Company Registration Number:
03230603 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2021

Period of accounts

Start date: 01 October 2020

End date: 30 September 2021

Contents of the Financial Statements

for the Period Ended 30 September 2021


Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

Balance sheet

As at 30 September 2021

	2021 £	2020 £
Fixed Assets:	11,263	8,245
Current assets:	3,504	9,700
Creditors: amounts falling due within one year:		( 500 )
Net current assets (liabilities):	3,504	9,200
Total assets less current liabilities:	14,767	17,445
Creditors: amounts falling due after more than one year:	( 18,476 )	( 17,126 )
Total net assets (liabilities):	( 3,709 )	319
Capital and reserves:	( 3,709 )	319

Balance sheet continued

For the year ending 30 September 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 June 2022
And Signed On Behalf Of The Board By:

Name: Prof Thomas Rademacher
Status: Director

The notes form part of these financial statements

Footnotes to the Financial Statements

for the Period Ended 30 September 2021

1. Employee Information

Average number of employees: 0

Footnotes to the Financial Statements

for the Period Ended 30 September 2021

2. Off balance sheet disclosure

No



Registered office:		2a Dunmore Court Lascaux Pharma 2a Dunmore Court, Wootton Road Abingdon Oxon OX13 6BH


Company Registration Number:		03230603 (England and Wales)

Accounts Submission